# Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

> **NCT01220167** · PHASE1 · COMPLETED · sponsor: **Aquestive Therapeutics** · enrollment: 18 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Ondansetron 8 mg ODFS without water
- **DRUG:** Ondansetron 8 mg ODFS with water
- **DRUG:** Zofran ODT (ondansetron 8 mg) without water

## Key facts

- **NCT ID:** NCT01220167
- **Lead sponsor:** Aquestive Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220167, "Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01220167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*